Text this: Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset

  ______     ___               __   __   __   __  
 /_   _//   / _ \\    ____     \ \\/ //  \ \\/ // 
   | ||    | / \ ||  |    \\    \ ` //    \   //  
  _| ||    | \_/ ||  | [] ||     | ||     / . \\  
 /__//      \___//   |  __//     |_||    /_//\_\\ 
 `--`       `---`    |_|`-`      `-`'    `-`  --` 
                     `-`